Literature DB >> 2666433

Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.

S Ashkenazi1, T G Cleary.   

Abstract

Shiga toxin and the closely related Shiga-like toxins produced by Escherichia coli represent a group of very similar cytotoxins that may play an important role in diarrheal disease and hemolytic uremic syndrome. These toxins have the same biologic activities and according to recent studies also share the same binding receptor, globotriosyl ceramide (Gb3). They are currently detected, on the basis of their ability to damage several cell lines, by using expensive and tedious assays that require facilities for and experience with tissue cultures and are therefore most suitable for research laboratories. We have developed a rapid method to detect Shiga toxin and Shiga-like toxin I based on specific binding to their Gb3 natural receptor, which was coated onto microdilution plates. Bound toxin was then detected by enzyme-linked immunosorbent assay (ELISA) with monoclonal antibodies. The sensitivity of the Gb3 ELISA was 0.2 ng (2 ng/ml) of purified toxin. The assay was positive with sonic extracts of Shigella dysenteriae serotype 1 strain 6OR (a Shiga toxin producer), E. coli serotype O26:H11 strain H30, and E. coli serotype O157:H7 (both Shiga-like toxin I producers). The assay was very specific in that no cross-reactivity was noted with purified cholera toxin, E. coli heat-labile and heat-stable enterotoxins, and Clostridium difficile cytotoxin, or sonic extracts of other cytotoxin-producing organisms, such as other shigellae, pathogenic and nonpathogenic E. coli, Salmonella spp., Campylobacter spp., and Aeromonas spp. These results were in complete agreement with a [3H]thymidine-labeled HeLa cell cytotoxicity assay and with detection of the structural genes by DNA hybridization studies with a Shiga-like toxin I probe. Quantitative analysis showed a high correlation between Gb3 ELISA and HeLa cell assay when fractions obtained at various stages of toxin purification were examined by both methods (r = 0.99, P < 0.01). This rapid Gb3 ELISA is sensitive and specific and may be diagnostically useful in cytotoxin-related infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666433      PMCID: PMC267516          DOI: 10.1128/jcm.27.6.1145-1150.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli.

Authors:  M P Jackson; J W Newland; R K Holmes; A D O'Brien
Journal:  Microb Pathog       Date:  1987-02       Impact factor: 3.738

2.  An improved colony hybridization method with significantly increased sensitivity for detection of single genes.

Authors:  R Maas
Journal:  Plasmid       Date:  1983-11       Impact factor: 3.466

3.  Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.

Authors:  A D O'Brien; J W Newland; S F Miller; R K Holmes; H W Smith; S B Formal
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

4.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

5.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

6.  Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin.

Authors:  K Eiklid; S Olsnes
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

7.  Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli.

Authors:  J W Newland; N A Strockbine; S F Miller; A D O'Brien; R K Holmes
Journal:  Science       Date:  1985-10-11       Impact factor: 47.728

8.  Rapid GM1-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin.

Authors:  A M Svennerholm; G Wiklund
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

9.  Shiga-like cytotoxin production by enteropathogenic Escherichia coli serogroups.

Authors:  T G Cleary; J J Mathewson; E Faris; L K Pickering
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

10.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  17 in total

1.  Evaluation of enzyme-linked immunosorbent assays and a PCR test for detection of shiga toxins for shiga toxin-producing Escherichia coli in cattle herds.

Authors:  Monserrat Segura-Alvarez; Heinz Richter; Franz J Conraths; Lutz Geue
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Role of avian pathogenic Escherichia coli virulence factors in bacterial interaction with chicken heterophils and macrophages.

Authors:  Melha Mellata; Maryvonne Dho-Moulin; Charles M Dozois; Roy Curtiss; Brigitte Lehoux; John M Fairbrother
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

3.  The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide.

Authors:  Michael J Smith; Humberto M Carvalho; Angela R Melton-Celsa; Alison D O'Brien
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

4.  A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2.

Authors:  Sharon X Wen; Louise D Teel; Nicole A Judge; Alison D O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

5.  Prevalence of verocytotoxigenic Escherichia coli in ground beef, pork, and chicken in southwestern Ontario.

Authors:  S C Read; C L Gyles; R C Clarke; H Lior; S McEwen
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

6.  Membrane Adhesion via Glycolipids Occurs for Abundant Saccharide Chemistries.

Authors:  Victoria M Latza; Bruno Demé; Emanuel Schneck
Journal:  Biophys J       Date:  2020-02-12       Impact factor: 4.033

7.  Verotoxin induces hemorrhagic lesions in rat small intestine. Temporal alteration of vasoactive substances.

Authors:  H Tashiro; S Miura; I Kurose; D Fukumura; H Suzuki; M Suematsu; M Yoshioka; M Tsuchiya; A Kai; Y Kudoh
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

8.  Rapid and sensitive method for detection of Shiga-like toxin-producing Escherichia coli in ground beef using the polymerase chain reaction.

Authors:  V P Gannon; R K King; J Y Kim; E J Thomas
Journal:  Appl Environ Microbiol       Date:  1992-12       Impact factor: 4.792

9.  Role of virulence factors in resistance of avian pathogenic Escherichia coli to serum and in pathogenicity.

Authors:  Melha Mellata; Maryvonne Dho-Moulin; Charles M Dozois; Roy Curtiss; Peter K Brown; Pascal Arné; Annie Brée; Clarisse Desautels; John M Fairbrother
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Human milk secretory antibodies against attaching and effacing Escherichia coli antigens.

Authors:  Marita Noguera-Obenza; Theresa J Ochoa; Henry F Gomez; M Lourdes Guerrero; Irene Herrera-Insua; Ardythe L Morrow; Guillermo Ruiz-Palacios; Larry K Pickering; Carlos A Guzman; Thomas G Cleary
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.